Veralto Other Non-Current Liabilities increased by 25.6% to $701.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.8%, from $536.00M to $701.00M. Over 3 years (FY 2022 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 6.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $462.00M | $479.00M | $410.00M | $446.00M | $426.00M | $438.00M | $517.00M | $536.00M | $563.00M | $572.00M | $558.00M | $701.00M |
| QoQ Change | — | +3.7% | -14.4% | +8.8% | -4.5% | +2.8% | +18.0% | +3.7% | +5.0% | +1.6% | -2.4% | +25.6% |
| YoY Change | — | — | -11.3% | — | — | -8.6% | +26.1% | +20.2% | +32.2% | +30.6% | +7.9% | +30.8% |